Our data showed that NRF2 deficiency aggravated diabetes-induced myocardial hypertrophy, fibrosis, oxidative stress, and cardiomyocyte ferroptosis; however, cardiac-specific NRF2 overexpression by AAV9 greatly slowed the progression of DCM (Figure 5). Here, NFE2L2 is linked to cardiac hypertrophy.